Staging for Melanoma - Toward a New Paradigm?-Reference-Cited by-同舟云学术

Staging for Melanoma - Toward a New Paradigm?

Published:2020-01-24 Issue:9 Volume:112 Page:873-874
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Elder David E¹^ORCID,Karakousis Giorgos¹^ORCID,Scolyer Richard A²^ORCID

Affiliation:

1. Hospital of the University of Pennsylvania, Division of Anatomic Pathology, Philadelphia, PA 19104, USA

2. Melanoma Institutes Australia, The University of Sydney Royal Prince Alfred Hospital and New South Wales Health Pathology, Faculty of Health and Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djaa009/33153600/djaa009.pdf

Reference10 articles.

1. Melanoma prognosis – accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition;Bajaj;J Natl Cancer Inst,2020

2. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma;Breslow;Ann Surg,1970

3. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas;Gimotty;J Clin Oncol,2007

4. Long-term survival of patients with thin (T1) cutaneous melanomas: a Breslow thickness cut point of 0.8 mm separates higher-risk and lower-risk tumors;Lo;Ann Surg Oncol,2018

5. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer Eighth Edition cancer staging manual;Gershenwald;CA Cancer J Clin,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis;The Lancet Oncology;2024-04

2. 18 F‐FDG positron emission tomography–computed tomography has a low positive predictive value for detecting occult recurrence in asymptomatic patients with high‐risk Stages IIB, IIC, and IIIA melanoma;Journal of Surgical Oncology;2021-11-06